Following the enactment of HB 302, a significant legislative reform in Hawaii's medical cannabis program, NuggMD has announced the expansion of its telehealth services to all adult Hawaiians. This development marks a pivotal moment in the state's approach to medical cannabis, removing the previous requirement for a set of qualifying medical conditions and instead allowing medical providers to recommend cannabis based on their discretion. The law also officially sanctions the use of telehealth for medical cannabis evaluations, a move that NuggMD estimates could benefit approximately 115,000 regular cannabis users in Hawaii.
The scarcity of healthcare providers willing to certify patients for cannabis use in Hawaii has been a notable barrier to access. With only 241 out of over 15,000 licensed physicians and APRNs currently participating in the program, telehealth services like those offered by NuggMD are critical to fulfilling the legislative intent behind HB 302. Robert Brock, VP of marketing at NuggMD, emphasized the importance of telehealth in expanding access to medical cannabis, stating, "Most cannabis consumers use the plant for wellness, and absent federal reform, telehealth is the best way to give more people more access."
NuggMD's platform offers medical cannabis evaluations for $98, operating from 8 am to 10 pm seven days a week without the need for an appointment. Notably, patients who do not qualify for Hawaii's medical cannabis program will not be charged for their evaluation. This approach underscores NuggMD's commitment to making medical cannabis accessible to those who may benefit from it, aligning with the broader implications of HB 302 for patient care and wellness in Hawaii.
For more information on NuggMD's services in Hawaii, visit https://www.nuggmd.com/hawaii. This expansion not only represents a significant step forward for medical cannabis access in Hawaii but also highlights the evolving landscape of cannabis legislation and telehealth's role in shaping the future of patient care.
